Histone deacetylase inhibitors
AssigneeThe Regents of the University of California
InventorsAnandasankar Ray, Sachiko Yamanaka
Life of this patent
Estimating the term…
Abstract
Provided herein are compounds that act as histone deacetylase (HDAC) inhibitors, and can affect expression of genes in vivo and in vitro. These HDAC inhibitors are generally volatile compounds that can be administered as a gas or vapor. Such inhibitors can be used as therapeutics for numerous disease conditions, such as a variety of cancers, neural degenerative diseases, neurological diseases, senescence, and infectious diseases.
Claims5
A method for protecting against neurodegeneration in Huntington's disease in a subject in need thereof, comprising administering to the subject via inhalation an effective amount of diacetyl.
Dependencies are inferred from the claim text.